| Tag | Content |
|---|
EnhancerAtlas ID | HS147-02337 |
Organism | Homo sapiens |
Tissue/cell | NHEK |
Coordinate | chr1:94269270-94271300 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| Foxq1 | MA0040.1 | chr1:94270225-94270236 | AATTGTTTATT | + | 6.02 | | HSF1 | MA0486.2 | chr1:94270235-94270248 | TTCTGGAATTTTC | + | 6.17 | | NFAT5 | MA0606.1 | chr1:94270929-94270939 | AATGGAAAAT | - | 6.02 | | NFATC1 | MA0624.1 | chr1:94270929-94270939 | AATGGAAAAT | - | 6.02 | | NFATC3 | MA0625.1 | chr1:94270929-94270939 | AATGGAAAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
| SE_35048 | chr1:94266068-94273829 | HeLa |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 94269998 | 94270414 | | chr1 | 94270973 | 94271107 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I093803 | chr1 | 94268721 | 94271773 |
|
Enhancer Sequence | ATCAAAGTTA ATTTTATTCT GACCCAAGTT TAAGAACTAT AGCTTGGAAA CAAACTCAGG 60
GAACACTGAG AAGGCGTCCC CAGATGGGTA CAGGAGGCAC AGTATTTATA TGTTTTGCAA 120
CACAGAAAAT GAAAACAGGG AGCAGTGAAG CAAAGGTGAC ATTCTTAAAA TATGCTATTG 180
ATGTATATAG GGTAAAAGTT TAATGCATAT GTAGGCATCT TAGGTTCTGG AGAGGGATGA 240
TTGATCCTAT CCTGCCTCTG TGCTTCATCT GATAGGCAAA GTGGCCATAA GTACATGTCA 300
GTGAAATATC TGAAGGCTGG ACATAGCAGC TTATGCCTGT AATCCCAGTA CTTTGGGAGG 360
CTGAGGTGGG AGGATGGCTT ACAGCCAGGA GTTTGGGACC AGCCTATACA ACACAGTGAG 420
ACCCCATCTC TATTTCAAAT ACATTAAAAA ATAATTTGTT TTTAATTTTG GCAAACTCCA 480
GCCTCACAGG TGAGAATTCA GCTTTAATTC GTAGGCCTAG CTTCTATTAC CCATATGCCT 540
AACCTACAGC CATTTTGGAC CTCTTGTAAA AATGAAATTT TTGTTCAAAT TTTTCTTCTT 600
CTGAGATAGG TATTATGCAT ACCTATGATA AAGTTTAATT TACAAACTAG GCACAGTAAG 660
AGATTAACAA CAATAACTAA CAGTAAAATA GAACAATTAT AATAATATGC TAGTATCACT 720
ACTCTTGCAC TTTGGGGGCA GTATTAAGTA AAACAGGGAT TCCTTGAACA CAAGTACTGT 780
GATACCATGA GGGCCAATCT GATAACCAAG ATGGCTATTA AGTGACTAAC AGACAGGCAG 840
TGTATATAGT GTGCAGCGCT GGACAAAGAA ATGATTCACA TCCTGGGCAG GACAGAGTTG 900
GCCAGCATGA GATTTTATCG TACTACTCAG AACAGGATGC AATTTAAAAC TTGGAAATTG 960
TTTATTTCTG GAATTTTCCA CTTAATATTT TTGGACCGAA GTTGACTGCA AGTAACTGAA 1020
ACTGCAGAAA GTGAAACAGT GGATAAGGAG GAACCACTGT GTAACAATTT GTTTATCCAT 1080
TCATCAGTTG ATGAATATTT GAGTTGTTTC CAGTCTTTAG CCATCATGGA TAGAATAAAC 1140
TTGTTATGAA CACTTGTGTA CAAGTCTTTG TGTGGAATTA TGTTTCACGT CTTTTGGGTA 1200
AATACTTATG AGTGGAATTT CTGGACCCTA AGGTAAATGC ATGTTTAATT TATTTTAAAA 1260
CACAACTGCT TCCATTTTAA TGCAGCAATT TTTCTCACAA TTTATTCTAA ATAAAAAATC 1320
ATGGATGTGT GTAATGATTT AGCTACCAGG ATCTTCATCA TAACATTGTT TATACATTTG 1380
CTACAATTAA ACATACAACC ATGTTATAGA GTACCATACA GCAATTTAAG TTCAGGAATC 1440
TTCTAGCTCA GGAATTAAAA TGTCATAAGC CTACAATAAA GAAGAACATA GGAATCTGCT 1500
TTATAGAGAT TTCAACAGAT TTCTTGGAAA CAGAAATAGA TGTATGAATA CTGACTAATA 1560
CAGCAGGGTG GAGTGAGCTG CAGCTAAGGG ATCAAGATTC TCTCCACAGA AGATGAGAGG 1620
TGCTTCAGTC TGGAAATGAA AAGGATCCTA GATAGCAGTA ATGGAAAATG GGGCTGAAAG 1680
CCATTAAAGT TCTATATGTG CAGCAGTTGA CACCCTCGCT TGTATAGATT AGACAGGTGT 1740
CAATCACCTT CTTTCAGTAA AACACTGGAC AGTGTGTCTC TGAAGACACT GTATAGACTG 1800
CCTGTGGAGA ACTAGGGCAG CCAACATGGG ATTTGGAAGT CCAGAGTGAA GCCCTCTGCA 1860
TTCCTGCCTT TAGGACCCTC AACAAAAAGA ATGACTTATT GTCAACATTC CCTGACAGTG 1920
GACAAGTTCT CCCTATGTTC TTAAGATTTT CTATCAGCCT CCTTATTGCC TCAGTCTTAA 1980
ACAGAAATGA AAAGCCAAGA GTAAACAAAC ATGAGAGGAA AGTCTGCAAT 2030
|
